Zobrazeno 1 - 10
of 399 726
pro vyhledávání: '"CELL transplantation"'
Autor:
Yuan F; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China., Li M; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China., Wei X; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China., Fu Y; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China.
Publikováno v:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2024 Aug; Vol. 41 (5), pp. 322-335. Date of Electronic Publication: 2024 Mar 04.
Autor:
Paviglianiti A; Department of Medicine, Unit of Endocrinology and Diabetes, Università Campus Bio-Medico di Roma, Rome, Italy; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain. Electronic address: annalisa.paviglianiti@gmail.com., Bianchessi A; Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Avenoso D; Department of Hematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Radici V; Unit of Blood Diseases and Stem Cell Transplantation, ASST-Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Domingo MP; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Pozzilli P; Department of Medicine, Unit of Endocrinology and Diabetes, Università Campus Bio-Medico di Roma, Rome, Italy., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.
Publikováno v:
Clinical nutrition ESPEN [Clin Nutr ESPEN] 2024 Oct; Vol. 63, pp. 400-408. Date of Electronic Publication: 2024 Jul 04.
Autor:
The Lancet Haematology
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Sep; Vol. 11 (9), pp. e629.
Autor:
Sisinni L; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid. Electronic address: sisinniluisa@gmail.com., Monserrate GXA; Servicio de Hematología, Hospital Clínico Universitario de Valladolid, Valladolid., Hurtado JMP; Unidad de Hematología Pediátrica, UGC Hematología, Hospital Virgen del Rocío, Sevilla., Panesso M; Servicio de Oncología y Hematología Pediátrica, Unidad HSCT. Hospital Universitari Vall d'Hebron, Barcelona., Molina B; Hematología-Oncología Pediátrica, Hospital Niño Jesús, Madrid., Fuentes C; Hematologia Pediátrica, Hospital La Fe, Valencia., Fuster JL; Sección de Oncohematología Pediátrica, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia., Verdu-Amoros J; Hematología Pediátrica, Hospital Clínico Universitario; INCLIVA-Biomedical Research Institute, Valencia., Regueiro A; Hematologia pediátrica, Hospital Santiago de Compostela., Palomo P; Hematología Pediátrica, Hospital Universitario Central de Asturia, Oviedo., Beléndez C; Hematología Pediátrica, Hospital Gregorio Marañon, Madrid., Pascual A; Hematología pediátrica, Hospital de Malaga., Badell I; Hematología-Oncología Pediátrica, Hospital Santa Creu i Sant Pau, Barcelona, Spain., Mozo Y; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid., Bueno D; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid., Pérez-Martínez A; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid., Fernández JM; Hematologia Pediátrica, Hospital La Fe, Valencia., Vicent MG; Hematología-Oncología Pediátrica, Hospital Niño Jesús, Madrid., de Heredia CD; Servicio de Oncología y Hematología Pediátrica, Unidad HSCT. Hospital Universitari Vall d'Hebron, Barcelona.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Oct; Vol. 30 (10), pp. 1015.e1-1015.e13. Date of Electronic Publication: 2024 Jul 25.
Autor:
El Masri J; Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon.; Faculty of Medical Sciences, Lebanese University, Beirut 1533, Lebanon., Fadlallah H; Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon., Al Sabsabi R; Faculty of Medical Sciences, Lebanese University, Beirut 1533, Lebanon., Afyouni A; Faculty of Medical Sciences, Lebanese University, Beirut 1533, Lebanon., Al-Sayegh M; Biology Division, New York University Abu Dhabi, Abu Dhabi 2460, United Arab Emirates., Abou-Kheir W; Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon.
Publikováno v:
Cells [Cells] 2024 Sep 09; Vol. 13 (17). Date of Electronic Publication: 2024 Sep 09.
Autor:
Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; H. Lee Moffitt Cancer Center, Tampa, Florida, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Al-Ramahi J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Noor J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Vyas A; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Mahmoudjafari Z; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Abhyankar S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA., Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.
Publikováno v:
Transfusion [Transfusion] 2024 Aug; Vol. 64 (8), pp. 1402-1406. Date of Electronic Publication: 2024 Jun 07.
Autor:
Kawamura S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan., Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan., Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan., Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan., Hayashi H; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan., Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan., Ohigashi H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan., Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan., Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan., Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan., Ishimaru F; Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan., Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan., Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Jichi Medical University, Shimotsuke, Japan., Yakushijin K; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan., Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address: nakasone-tky@umin.ac.jp.
Publikováno v:
Cytotherapy [Cytotherapy] 2024 Nov; Vol. 26 (11), pp. 1353-1361. Date of Electronic Publication: 2024 Jun 12.
Autor:
Horikawa S; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Kishimoto K; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Uemura S; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Hyodo S; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Kozaki A; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Saito A; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Ishida T; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Mori T; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Hasegawa D; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan., Kosaka Y; Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan.
Publikováno v:
Pediatric transplantation [Pediatr Transplant] 2024 May; Vol. 28 (3), pp. e14728.
Autor:
Letailleur V; Hematology Department, Nantes University Hospital, Nantes, France., Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France., Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.; INSERM UMR1232, CRCINA IRS-UN, University of Nantes, Nantes, France., Garnier A; Hematology Department, Nantes University Hospital, Nantes, France., Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France., Jullien M; Hematology Department, Nantes University Hospital, Nantes, France., Antier C; Hematology Department, Nantes University Hospital, Nantes, France., Béné MC; Hematology Biology Department, Nantes University Hospital, Nantes, France., Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.; INSERM UMR1232, CRCINA IRS-UN, University of Nantes, Nantes, France.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2370970. Date of Electronic Publication: 2024 Jul 08.
Autor:
Kim N; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Min GJ; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Im KI; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Nam YS; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Song Y; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Lee JS; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Oh EJ; Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Chung NG; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Jeon YW; Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Lee JW; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Cho SG; Institute for Translational Research and Molecular Imaging, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Jun 19; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 19.